
November 20, 2017 - By Henry Gaston
Tower Bridge Advisors decreased Unilever Plc Adr (UL) stake by 2.43% reported in 2017Q2 SEC filing. Tower Bridge Advisors sold 2,115 shares as Unilever Plc Adr (UL)’s stock rose 11.00%. The Tower Bridge Advisors holds 84,829 shares with $4.59B value, down from 86,944 last quarter. Unilever Plc Adr now has $166.06B valuation. The stock rose 1.40% or $0.77 reaching $55.77. About 169,823 shares traded. Unilever plc (ADR) (NYSE:UL) has risen 20.68% since November 20, 2016 and is uptrending. It has outperformed by 3.98% the S&P500. Ultragenyx Pharmaceutical Incorporated (NASDAQ:RARE) had a decrease of 2.39% in short interest. RARE’s SI was 4.43M shares in November as released by FINRA. Its down 2.39% from 4.54 million shares previously. With 431,300 avg volume, 10 days are for Ultragenyx Pharmaceutical Incorporated (NASDAQ:RARE)’s short sellers to cover RARE’s short positions. The SI to Ultragenyx Pharmaceutical Incorporated’s float is 11.48%. About 7,282 shares traded. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) has declined 6.49% since November 20, 2016 and is downtrending. It has underperformed by 23.19% the S&P500.Among 12 analysts covering Unilever (NYSE:UL), 4 have Buy rating, 2 Sell and 6 Hold. Therefore 33% are positive. Unilever had 15 analyst reports since July 24, 2015 according to SRatingsIntel. Jefferies upgraded the stock to “Buy” rating in Tuesday, December 13 report. Macquarie Research initiated Unilever plc (ADR) (NYSE:UL) on Friday, March 17 with “Outperform” rating. On Monday, August 22 the stock rating was initiated by Bernstein with “Outperform”. The firm earned “Neutral” rating on Monday, February 27 by Bank of America. The rating was upgraded by JP Morgan to “Overweight” on Tuesday, January 12. The rating was downgraded by JP Morgan on Wednesday, December 7 to “Neutral”. The rating was downgraded by Goldman Sachs on Wednesday, August 12 to “Neutral”. Argus Research initiated the shares of UL in report on Friday, November 17 with “Hold” rating. The stock of Unilever plc (ADR) (NYSE:UL) has “Sell” rating given on Thursday, August 10 by RBC Capital Markets. As per Monday, January 23, the company rating was downgraded by Barclays Capital.Tower Bridge Advisors increased Lord Abbett Invt Tr S stake by 110 shares to 11,616 valued at $49.83 million in 2017Q2. It also upped Cognizant Technology (NASDAQ:CTSH) stake by 3,103 shares and now owns 177,945 shares. Halliburton Co. (NYSE:HAL) was raised too. Among 21 analysts covering Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), 12 have Buy rating, 1 Sell and 8 Hold. Therefore 57% are positive. Ultragenyx Pharmaceutical Inc had 52 analyst reports since July 27, 2015 according to SRatingsIntel. Canaccord Genuity maintained Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on Thursday, November 16 with “Buy” rating. As per Friday, February 19, the company rating was initiated by Leerink Swann. The rating was maintained by Canaccord Genuity on Friday, July 28 with “Buy”. The stock of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) has “Buy” rating given on Tuesday, December 22 by Canaccord Genuity. The firm has “Sell” rating given on Monday, November 14 by Citigroup. As per Wednesday, April 19, the company rating was downgraded by H.C. Wainwright. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, August 22. The firm has “Sell” rating given on Thursday, September 3 by Citigroup. The stock of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) earned “Buy” rating by Canaccord Genuity on Tuesday, August 22. As per Friday, July 28, the company rating was maintained by Stifel Nicolaus.Investors sentiment increased to 1.84 in Q2 2017. Its up 0.75, from 1.09 in 2017Q1. It is positive, as 17 investors sold Ultragenyx Pharmaceutical Inc shares while 32 reduced holdings. 19 funds opened positions while 71 raised stakes. 40.50 million shares or 1.11% more from 40.06 million shares in 2017Q1 were reported. Td Asset holds 37,728 shares. Ww has invested 0% in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE). Teachers Retirement Systems Of The State Of Kentucky holds 42,218 shares. Alps Incorporated invested in 38,165 shares or 0.02% of the stock. Next Financial Inc reported 0% in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE). Clearbridge Limited Liability Company reported 1,097 shares. Rhenman & Asset Mngmt Ab accumulated 0.32% or 35,573 shares. Nationwide Fund Advsrs holds 0.01% or 60,023 shares in its portfolio. 101,774 are owned by Ameriprise. Natl Bank Of America De reported 44,024 shares stake. Baker Bros L P reported 25,000 shares. 26,035 are owned by Proshare Advisors Limited Liability Com. Wellington Mgmt Grp Inc Llp holds 0.08% in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) or 5.25 million shares. Capital Int Sarl, a California-based fund reported 124,320 shares. Colorado-based Public Employees Retirement Association Of Colorado has invested 0% in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE).Ultragenyx Pharmaceutical Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $2.04 billion. The Firm is focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. It currently has negative earnings. The Company’s clinical-stage pipeline consists of two product categories: biologics , and small-molecule substrate replacement therapies.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
